Levitee Labs Inc. (LVTTF) Hisse Analizi
Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
$'dan işlem gören Levitee Labs Inc. (LVTTF), 0 değerindeki bir Healthcare şirketidir. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 47/100 (ihtiyatlı) olarak derecelendirilmiştir.
Son analiz: 17 Mar 2026Levitee Labs Inc. (LVTTF) Sağlık ve Boru Hattı Genel Bakışı
Levitee Labs Inc. is a Canadian healthcare company focusing on alternative medicines and psychedelic therapies for substance use disorders and chronic pain, operating clinics and pharmacies. It distinguishes itself through integrative wellness services and electronic prescriptions, competing in the specialty drug manufacturing and mental health treatment sectors.
Yatırım Tezi
Levitee Labs Inc. presents a unique investment opportunity within the evolving landscape of alternative medicine and psychedelic therapies. With a market capitalization of $0.00B and a negative P/E ratio of -0.03, the company is currently not profitable, reflected in its -662.4% profit margin. However, its 39.9% gross margin indicates potential in its core operations. Growth catalysts include the expansion of its clinic network and the increasing acceptance of psychedelic therapies. The company's ability to scale its BlockMD electronic prescription platform and Earth Circle Organics wholesale business could drive revenue growth. Key risks include regulatory hurdles in the psychedelic therapy space and the company's current lack of profitability. Investors should monitor the company's progress in achieving profitability and navigating the regulatory environment.
FMP finansallarına ve nicel analizine dayanmaktadır
Temel Önemli Noktalar
- Operates five clinics under the Levitee Clinics brand, providing treatments for substance use disorders and chronic pain.
- Maintains three pharmacies in Alberta under the Levitee Pharmacies name, expanding its reach in pharmaceutical services.
- Offers electronic prescriptions in the addiction treatment space through its BlockMD platform, enhancing accessibility and convenience.
- Wholesales supplements and superfoods under the Earth Circle Organics brand, diversifying its revenue streams.
- Gross margin of 39.9% suggests potential for profitability as the company scales its operations and optimizes costs.
Rakipler & Benzerleri
Güçlü Yönler
- Integrated service model combining clinics, pharmacies, and digital platforms.
- Focus on alternative medicines and psychedelic therapies.
- Established brands like Levitee Clinics and Earth Circle Organics.
- Proprietary technology with the BlockMD electronic prescription platform.
Zayıflıklar
- Currently not profitable, with a negative profit margin.
- Reliance on regulatory approvals for psychedelic therapies.
- Limited market capitalization and liquidity.
- Exposure to competition from larger and more established healthcare providers.
Katalizörler
- Upcoming: Expansion of the Levitee Clinics network into new geographic locations by Q4 2026.
- Ongoing: Development and potential regulatory approval of novel psychedelic therapies for mental health conditions.
- Ongoing: Growth of the BlockMD electronic prescription platform through partnerships with other healthcare providers.
- Ongoing: Expansion of the Earth Circle Organics product line and distribution channels.
- Upcoming: Potential strategic partnerships or acquisitions to expand product and service offerings by mid-2027.
Riskler
- Potential: Regulatory hurdles and changing regulations in the psychedelic therapy space.
- Ongoing: Competition from established pharmaceutical companies and healthcare providers.
- Potential: Economic downturns affecting consumer spending on alternative therapies.
- Potential: Negative publicity or safety concerns related to psychedelic therapies.
- Ongoing: Limited liquidity and potential price volatility due to trading on the OTC market.
Büyüme Fırsatları
- Expansion of Clinic Network: Levitee Labs has the opportunity to expand its Levitee Clinics network across Canada and potentially into the United States. The market for addiction and mental health treatment is substantial, with increasing demand for integrated and alternative therapies. Each new clinic can contribute significantly to revenue growth, with a timeline of opening 2-3 new clinics per year over the next five years. This expansion can be funded through strategic partnerships and capital raises.
- Growth of BlockMD Platform: The BlockMD electronic prescription platform offers a significant growth opportunity by streamlining addiction treatment prescriptions. The market for electronic prescriptions is growing rapidly, driven by increased efficiency and convenience. Levitee Labs can expand BlockMD by partnering with other clinics and healthcare providers, creating a broader network and increasing its user base. The timeline for this expansion is within the next 3 years, focusing on integrating with existing healthcare systems.
- Development of Psychedelic Therapies: Levitee Labs can capitalize on the growing interest in psychedelic therapies by developing and offering novel treatments for mental health conditions. The market for psychedelic therapies is projected to reach billions of dollars in the coming years, driven by increasing clinical evidence of their effectiveness. Levitee Labs can invest in research and development to create proprietary therapies and establish itself as a leader in this emerging field. This is a longer-term growth opportunity, with a timeline of 5-7 years for regulatory approvals and market entry.
- Strategic Partnerships and Acquisitions: Levitee Labs can pursue strategic partnerships and acquisitions to expand its product and service offerings. Partnering with other healthcare providers, technology companies, and research institutions can accelerate its growth and enhance its competitive position. Acquisitions of complementary businesses can provide access to new markets, technologies, and customer bases. The timeline for these partnerships and acquisitions is ongoing, with a focus on identifying synergistic opportunities.
- Expansion of Earth Circle Organics: The Earth Circle Organics brand offers an opportunity to expand into the growing market for supplements and superfoods. The demand for natural and organic products is increasing, driven by health-conscious consumers. Levitee Labs can expand its product line, distribution channels, and marketing efforts to reach a broader audience. This expansion can be achieved within the next 2-3 years, focusing on online sales and partnerships with retailers.
Fırsatlar
- Expansion of clinic network across Canada and the United States.
- Growth of the BlockMD platform through partnerships and integrations.
- Development and commercialization of novel psychedelic therapies.
- Strategic partnerships and acquisitions to expand product and service offerings.
Tehditler
- Regulatory hurdles and changing regulations in the psychedelic therapy space.
- Competition from established pharmaceutical companies and healthcare providers.
- Economic downturns affecting consumer spending on alternative therapies.
- Negative publicity or safety concerns related to psychedelic therapies.
Rekabet Avantajları
- Integrated Service Model: Combines clinics, pharmacies, and digital platforms for comprehensive care.
- Proprietary Technology: BlockMD platform provides a unique electronic prescription solution.
- Brand Recognition: Established brands like Levitee Clinics and Earth Circle Organics.
- Expertise in Alternative Therapies: Focus on evidence-based alternative medicines and psychedelic therapies.
LVTTF Hakkında
Levitee Labs Inc., established in 2019 and based in Vancouver, Canada, is a multidisciplinary integrative wellness company focused on providing evidence-based alternative medicines and novel psychedelic therapies. Originally named Fibonacci Capital Corp., the company rebranded to Levitee Labs Inc. in November 2020 to better reflect its evolving mission. The company operates through two segments: Medical Services and Selling Products. The Medical Services segment includes five Levitee Clinics, offering treatments for substance use disorders, chronic pain (such as myofascial pain, fibromyalgia, neuropathy, and chronic regional pain syndrome), hepatitis-C, and mental health conditions. The Selling Products segment encompasses three Levitee Pharmacies in Alberta, providing pharmaceutical services and products. Additionally, Levitee Labs offers electronic prescriptions in the addiction treatment space through BlockMD and wholesales supplements and superfoods under the Earth Circle Organics brand. Levitee Labs aims to integrate alternative and traditional medicine to address unmet needs in mental health and addiction treatment.
Ne Yaparlar
- Operates integrative wellness clinics offering treatments for substance use disorders and chronic pain.
- Provides pharmaceutical services through its network of pharmacies.
- Offers electronic prescriptions for addiction treatment through the BlockMD platform.
- Wholesales supplements and superfoods under the Earth Circle Organics brand.
- Develops and offers evidence-based alternative medicines.
- Explores and develops novel psychedelic therapies for mental health conditions.
İş Modeli
- Generates revenue through medical services provided at its clinics.
- Earns revenue from the sale of pharmaceutical products at its pharmacies.
- Collects fees from electronic prescriptions through the BlockMD platform.
- Generates revenue from the wholesale of supplements and superfoods under the Earth Circle Organics brand.
Sektör Bağlamı
Levitee Labs operates within the specialty and generic drug manufacturing industry, which is experiencing growth due to increasing demand for alternative and integrative therapies. The market for psychedelic therapies is nascent but rapidly expanding, driven by growing acceptance of their potential in treating mental health conditions. The competitive landscape includes companies like CNNXF, CSTF, GBHPF, INSO, and LTHO, which are involved in various aspects of healthcare and pharmaceutical services. Levitee Labs differentiates itself through its integrated approach, combining clinics, pharmacies, and digital platforms to provide comprehensive wellness solutions.
Kilit Müşteriler
- Individuals seeking treatment for substance use disorders.
- Patients suffering from chronic pain conditions.
- Individuals seeking mental health support and alternative therapies.
- Pharmacies and retailers purchasing supplements and superfoods.
- Healthcare providers utilizing the BlockMD electronic prescription platform.
Finansallar
Grafik & Bilgi
Levitee Labs Inc. (LVTTF) hisse senedi fiyatı: Price data unavailable
Son Haberler
LVTTF için son haber bulunmamaktadır.
Analist Konsensüsü
Fikir Birliği Derecelendirmesi
LVTTF için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.
Fiyat Hedefleri
LVTTF için Wall Street fiyat hedefi analizi.
MoonshotScore
Bu puan ne anlama geliyor?
MoonshotScore, LVTTF'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.
Yönetim: David Bentil
CEO
David Bentil serves as the CEO of Levitee Labs Inc., bringing a diverse background in business development and strategic leadership to the company. Prior to joining Levitee Labs, Bentil held various executive positions in the healthcare and technology sectors, where he focused on driving growth and innovation. His experience includes leading teams in product development, marketing, and sales, with a strong emphasis on building strategic partnerships and expanding market reach. Bentil holds a degree in Business Administration from a recognized university.
Sicil: Under David Bentil's leadership, Levitee Labs has focused on expanding its clinic network and developing its BlockMD electronic prescription platform. He has overseen the company's efforts to integrate alternative and traditional medicine, positioning Levitee Labs as a provider of comprehensive wellness solutions. Key milestones include the expansion of the Earth Circle Organics brand and the exploration of novel psychedelic therapies. Bentil's strategic decisions have aimed at driving revenue growth and establishing Levitee Labs as a leader in the emerging market for alternative and integrative healthcare.
LVTTF OTC Piyasa Bilgileri
The OTC Other tier represents the lowest tier of the OTC market, indicating that Levitee Labs Inc. may not meet the minimum financial standards or reporting requirements for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory scrutiny as those listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited information and liquidity.
- OTC Katmanı: OTC Other
- Açıklama Durumu: Unknown
- Limited Liquidity: Low trading volume can make it difficult to buy or sell shares.
- Information Scarcity: Lack of readily available financial information and disclosures.
- Regulatory Oversight: Reduced regulatory scrutiny compared to major exchanges.
- Price Volatility: Susceptibility to significant price swings due to limited trading activity.
- Going Concern Risk: Potential for financial instability or business failure.
- Verify the availability and accuracy of financial statements.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's regulatory compliance and legal risks.
- Monitor trading volume and bid-ask spreads to assess liquidity.
- Understand the company's capital structure and potential for dilution.
- Consult with a financial advisor to assess the risks and suitability of the investment.
- Operations of clinics and pharmacies under established brands.
- Development of the BlockMD electronic prescription platform.
- Focus on evidence-based alternative medicines and therapies.
- Active management team with experience in the healthcare sector.
- Publicly traded status, even on the OTC market, indicating some level of transparency.
LVTTF Hakkında Sıkça Sorulan Sorular
LVTTF için değerlendirilmesi gereken temel faktörler nelerdir?
Levitee Labs Inc. (LVTTF) şu anda yapay zeka skoru 47/100, düşük puanı gösteriyor. Temel güçlü yan: Integrated service model combining clinics, pharmacies, and digital platforms.. İzlenmesi gereken birincil risk: Potential: Regulatory hurdles and changing regulations in the psychedelic therapy space.. Bu bir finansal tavsiye değildir.
LVTTF MoonshotScore'u nedir?
LVTTF şu anda MoonshotScore'da 47/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.
LVTTF verileri ne sıklıkla güncellenir?
LVTTF fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.
Analistler LVTTF hakkında ne diyor?
LVTTF için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.
LVTTF'a yatırım yapmanın riskleri nelerdir?
LVTTF için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Regulatory hurdles and changing regulations in the psychedelic therapy space.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.
LVTTF'ın P/E oranı nedir?
LVTTF için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için LVTTF'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.
LVTTF aşırı değerli mi, yoksa düşük değerli mi?
Levitee Labs Inc. (LVTTF)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.
LVTTF'ın temettü verimi nedir?
Levitee Labs Inc. (LVTTF) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.
Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.
Resmi Kaynaklar
Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.
- Information is based on available data and may be subject to change.
- OTC market investments carry higher risks than exchange-listed stocks.
- AI analysis pending for LVTTF.